Categories: Finance and Commerce

Alliance Pharma agrees £350m takeover by fund manager

They also said DBAY’s support and private capital will enable Alliance to return to its acquisition strategy ‘more quickly than if it remained on the public market’.

RELATED ARTICLES

Previous

  • 1
  • Next

  • Top financier Edi Truell launches £245m bid for struggling… Saba lures in Herald shareholders with cash exit offer
  • Share this article

    Share

    Camillo Pane, non-executive chairman of Alliance, said: ‘The offer from DBAY represents an attractive and certain value in cash today for our shareholders.’

    Its proposed takeover comes amidst a frenzy of overseas companies taking advantage of depressed valuations to buy London-listed firms on the cheap.

    The proposal is also more than double the 29.4p closing price recorded in May 2024 when Alliance announced the departure of its chief executive and a third delay to the publication of its 2023 results in five weeks.

    She added that Alliance’s new owners will provide ‘operational expertise and significant additional capital to accelerate its strategy to grow through increased investment in new product innovation and development, M&A and expansion into new markets’.

    Headquartered in Chippenham, Wiltshire, Alliance enjoyed see-through revenue of £183million last year, as well as underlying earnings before nasties of £45million.

    Alliance’s new boss, Nick Sedgwick, has since been conducting a review to update the company’s strategy and formulating a plan to boost its long-term organic growth.

    The AIM-listed group blames this on high debts, operational challenges, a ‘restrictive funding environment’, and a declining share price.

    British businesses worth £145billion were snapped up in 2024, a 51 per cent rise on the previous year, according to the London Stock Exchange Group.

    It added that the firm ‘needs time away from the public market’ and extra financing sources in order to fulfil its growth potential.

    Directors at the business said the new plan had multiple uncertainties and would take ‘significant time and investment’ to achieve its potential benefits.

    DBAY believes the cost of Alliance’s public listing hurts its ability to prioritise long-term growth and did not provide ‘significant benefits’ for the company given its current liquidity levels.

    source

    Greg Smith

    Share
    Published by
    Greg Smith

    Recent Posts

    Cash Isa battle sees Trading 212 hike best rate TWICE in one week – how to bag 5.1%

    Trailing Trading 212*, Plum* and Moneybox are Monument Bank and Mansfield Building Society which are…

    3 weeks ago

    Will Howard’s girlfriend in tears after QB’s game-sealing pass in Ohio State’s national championship win

    Howard proved to be clutch down the stretch and led the Buckeyes to their first…

    3 weeks ago

    Saving lives and limbs on the high seas: The extraordinary world of early modern ship’s surgeons

    Psychological distress The challenges and risks of life at sea were not just physical but…

    3 weeks ago

    Walmart facing backlash over DEI policy reversal as shareholders, Dem officials urge them to reconsider

    McDonald’s, Amazon, Meta and American Airlines have also since announced a change to their DEI…

    3 weeks ago

    The long road ahead to rebuild life in Gaza

    What about the economy?The conflict has also had a "devastating impact" on Gaza's economy, said…

    3 weeks ago

    Mike McCarthy latest after Dallas Cowboys exit as NFL team ‘rolls out red carpet’ for Super Bowl champion coach

    The Bears have so far confirmed that they have interviewed 17 candidates to be their…

    3 weeks ago